feed,title,long_url,short_url
Benzinga,"After Disappointing Parkinson's Data, Sage Therapeutics' Dalzanemdor Flunks Mid-Stage Alzheimer's Study",https://benzinga.com/general/biotech/24/10/41228587/after-disappointing-parkinsons-data-sage-therapeutics-dalzanemdor-flunks-mid-stage-alzheimers-stu,https://da.gd/TuCDg6
Benzinga,What's Going On With Ambow Education Shares Premarket Tuesday?,https://benzinga.com/markets/equities/24/10/41228577/whats-going-on-with-ambow-education-shares-premarket-tuesday,https://da.gd/E5Ip3
